The accumulation and propagation of misfolded a-synuclein (a-Syn) is a central feature of Parkinson's disease and other synucleinopathies. Molecular compatibility between a fibrillar seed and its native protein state is a major determinant of amyloid selfreplication. We show that cross-seeded aggregation of human (Hu) and mouse (Ms) a-Syn is bidirectionally restricted. Although fibrils formed by Hu-Msa-Syn chimeric mutants can overcome this inhibition in cell-free systems, sequence homology poorly predicts their efficiency in inducing a-Syn pathology in primary neurons or after intracerebral injection into wild-type mice. Chimeric a-Syn fibrils demonstrate enhanced or reduced pathogenicities compared with wild-type Hu-or Ms-a-Syn fibrils. Furthermore, a-Syn mutants induced to polymerize by fibrillar seeds inherit the functional properties of their template, suggesting that transferable pathogenic and non-pathogenic states likely influence the initial engagement between exogenous a-Syn seeds and endogenous neuronal a-Syn. Thus, transmission of synucleinopathies is regulated by biological processes in addition to molecular compatibility.
In Brief Luk et al. show that cross-seeding between human (Hu) and mouse (Ms) a-synuclein (a-Syn) is less efficient than homologous seeding. Using a series of Hu-Ms chimeric proteins, they show that these fibrils likely adopt distinct and transferable configurations that determine the ability to induce Parkinson's disease-like pathology in neurons and in vivo.
INTRODUCTION
The propagation of misfolded proteins is an increasingly recognized disease mechanism in multiple neurodegenerative disorders (Jucker and Walker, 2013) . Synucleinopathies, such as Parkinson's disease (PD), are characterized by the intracellular accumulation of aggregated a-synuclein (a-Syn) (Lee and Trojanowski, 2006) . Recent work indicates that fibrillar a-Syn seeds the pathological conversion of normal neuronal a-Syn when pathological a-Syn derived from diseased brains or recombinant a-Syn pre-formed fibrils (PFFs) enter neurons and induces the formation of fibrillary structures similar to Lewy bodies (LBs) and Lewy neurites (LNs) that typify PD (Luk et al., 2012a; Recasens et al., 2014; Volpicelli-Daley et al., 2011) . Misfolded a-Syn propagation is further enhanced by the transfer of pathological a-Syn species from affected neurons to healthy ones (Desplats et al., 2009; Luk et al., 2012b) , suggesting that the stereotypical spread of a-Syn pathology along neuroanatomical pathways observed in PD patients results from a templated recruitment process reminiscent of that described for prion diseases (Braak et al., 2003; Dunning et al., 2013) .
Despite its potentially central role in disease, little is known about the initial steps by which pathological a-Syn seeds corrupt native cellular a-Syn. Studies of mammalian and yeast amyloids have established that pathological seeding across species is generally inefficient. Resistance to cross-species templating likely arises at the molecular level, at which sequence incompatibilities result in amyloid conformations or post-translational modifications that reduce the interface between the amyloid seed and substrate (Angers et al., 2010; Bett et al., 2012; Jones and Surewicz, 2005; Tessier and Lindquist, 2007) . Even single mismatches in amino acid sequence can greatly reduce the pathogenicity of amyloids or the susceptibility of a species as host for propagation (Santoso et al., 2000; Scott et al., 1993; Tycko, 2015) . Distinct conformational strains of fibrillar a-Syn that induce dissimilar histopathological phenotypes have also been identified (Bousset et al., 2013; Guo et al., 2013; Peelaerts et al., 2015; Woerman et al., 2015) , suggesting that tertiary and quaternary structure may influence disease pathogenesis in synucleinopathies.
The assembly kinetics of a-Syn indicate a nucleation-dependent recruitment process (Biere et al., 2000; Rochet and Lansbury, 2000; Wood et al., 1999) . Substitution of the human sequence at either position 53 or 87 with the native mouse residue accelerates fibrillization rates substantially (Kang et al., 2011) . Likewise, assembly rates for human-mouse chimeric a-Syn proteins fall between that of the two wild-type (WT) proteins and are proportional to their homology to WT mouse (Ms WT a-Syn). Past studies have focused primarily on de novo a-Syn fibrillization in cell-free systems, although seeded fibrillization may be particularly relevant to the cell-to-cell spread likely occurring in PD. Recent studies showed that PFFs generated from Ms WT a-Syn cause LBs and LNs within weeks after intracerebral injection in WT mice and are more potent than WT human (Hu WT ) a-Syn PFFs, which induce pathology on the scale of months (Luk et al., 2012a; Masuda-Suzukake et al., 2013) . We hypothesized that primary sequence differences between Ms WT and Hu WT a-Syn ( Figure 1A ; Larsen et al., 2009 ) account for this gap in seeding ability and designed a mutagenesis strategy targeting the seven divergent positions between Ms WT and Hu WT a-Syn to identify key residues and domains that facilitate efficient templated conversion of a-Syn in vitro, in cultured neurons, and in WT mice. Surprisingly, although sequence homology correctly predicted inefficient cross-seeding between Hu WT and Ms WT a-Syn in both cultured neurons and in WT mice, we found that in vitro seeding efficiencies of chimeric a-Syn PFFs correlated poorly with their ability to induce LBs and LNs in vivo. Finally, mutant a-Syn PFFs can confer this enhanced or reduced propagation capacity to monomers of another sequence, providing evidence that the ectopic seeding efficiencies observed arise from unique properties encoded within a-Syn PFF preparations.
RESULTS

Sequence Homology Predicts Efficiency of a-Syn
Cross-Seeding In Vitro Sequence homology between a misfolded protein (i.e., a fibrillar or oligomeric seed) and its native soluble monomer (substrate) strongly influences the efficiency with which amyloids initiate templated conversion (Cobb and Surewicz, 2009) . From a molecular perspective, the current hypothesis supports the concept that the rate of homologous or ''self'' recruitment (cis templating; Figure 1B , left path) occurs faster than that of cross-seeding, mainly because of delayed elongation caused by the reduced trans-seeding efficacy between the non-homologous seed and substrate. Once levels of converted substrate reach a critical threshold, cis-seeding of this sequence becomes the dominant kinetic factor, resulting in efficient elongation ( Figure 1B , right path).
To determine whether seeding by a-Syn PFFs also follows such a relationship, we first confirmed that full-length Hu WT , Ms WT , and a-Syn chimeras (in which divergent residues were substituted with the orthologous amino acids) are assembly competent ( Figures 1A and S1 ). Following incubation with agitation, all WT and chimeric a-Syn constructs formed fibrils averaging 12-15 nm in diameter as observed by electron microscopy ( Figure S1B ). Furthermore, PFFs showed comparable (>85%) levels of insoluble amyloid a-Syn after sedimentation and thioflavin T (ThT) binding, although ThT fluorescence intensity was not proportional to fibril quantity (Figures S1A and S1C and S2). Thus, the combination of Thr and Asn at positions 53 and 87 appears to restrict the ability to initiate pSyn inclusions in neurons. Altogether, these observations suggest that, in addition to sequence homology, there are biological processes that further regulate seeding at the cellular level.
C-Terminal Modifications Further Influence a-Syn Seeding in Neurons
Although only modest changes in in vitro seeding efficiency were observed for chimeras containing C-terminal substitutions beyond residue 87, the relative inactivity of Hu TN PFFs in neurons indicates that these remaining residues contribute significantly to the seeding of Ms WT PFFs in neurons. Besides positions 53 and 87, the primary sequences between Hu WT and Ms WT a-Syn differ at five additional residues (100, 103, 107, 121, and 122; Figure 1A ). We therefore expected that one or more additional substitutions to Hu TN at these positions would have a restorative effect on seeding when the resulting PFFs were added to neurons. Indeed, seeding activity of Hu TN PFFs could be restored by several of the substitutions, most prominently by reintroduction of the native mouse residue at 103 (i.e., Hu TNG ; Figure S4 ). Although Hu TNG and Hu TNY PFFs show significant rescue of seeding efficacy in neuronal culture, reintroduction of mutations both closer to (L100M) and farther from (D121G and N122S) the hydrophobic core of a-Syn elicited only partial recovery ( Figures S4C and S4E ).
To further test the role of the C terminus in neuronal seeding and its interplay with the residues at positions 53 and 87, we generated PFFs containing only residues 1-99 
Pathological Seeding Properties of PFFs Are Preserved In Vivo
The divergence in pathological seeding activities between chimeric a-Syn PFFs in neurons versus cell-free assays prompted us to evaluate whether PFFs have similar cross-seeding properties in vivo. C57Bl6/C3H mice were injected with either Ms WT or Hu WT PFFs by means of a single unilateral injection into the dorsal striatum, which induces Lewy-like pathology in multiple CNS regions connected to the injection site, including piriform cortex (Pir), frontal agranular cortex (FC), amygdala, and dopamine (DA) neurons of the substantia nigra pars compacta (SNpc) (Luk et al., 2012a; Masuda-Suzukake et al., 2013) . As expected, Ms WT PFFs induced a higher burden of a-Syn pathology compared with Hu WT PFFs when examined by immunohistochemistry (IHC) 30 days post-injection (dpi) in the Pir and FC, two regions that rapidly develop a-Syn inclusions after intrastriatal PFF inoculation. Whereas LBs were present in Pir and FC of Ms WT PFF treated animals at 30 dpi, the same regions in Hu WT PFF-injected mice showed only traces of LN-like accumulations, reflective of the early stages of seeded pathology (Osterberg et al., 2015) and consistent with inefficient cross-seeding between Hu WT and Ms WT a-Syn. We then asked whether the variations in seeding observed among chimeric PFFs in cultured neurons are preserved in vivo by examining the distribution of a-Syn pathology in mice injected with PFFs generated from Hu were devoid of a-Syn pathology in all areas examined by IHC for pSyn ( Figure 3 ) and misfolded a-Syn (Syn506; data not shown). The inability of Hu TN PFFs to induce a-Syn pathology was reversed by the reintroduction of the native mouse residue at 103, as Hu TNG PFFs elicited comparable levels of pathology with Hu S87N PFFs in these same regions. Thus, the induction of Lewy-like inclusions with chimeric a-Syn PFFs in mice is more congruent with data from our neuronal culture than from in vitro seeding studies and further suggests that these differences are underpinned by similar cellular processes.
Notably, the mitral cell layer (MCL) of the ipsilateral olfactory bulb, a discrete neuron population lacking direct projections to the injection site, also showed numerous pSyn inclusions after striatal injection of Ms WT , Hu S87N , and Hu TNG PFFs (Figure 3 , bottom row). The comparable overall distribution of a-Syn pathology induced by these PFFs also point to shared neuroanatomical routes of spread consistent with trans-cellular spread of misfolded a-Syn. Chimeric a-Syn Sequences Can Enhance or Suppress Pathological Seeding In Vivo To more precisely determine differences in the relative seeding by PFFs in vivo, we compared the extent of a-Syn pathology they induced over time in the amygdala, one of the first areas to develop LB-and LN-like pathology after intrastriatal PFF injections (Luk et al., 2012a resulted in mainly LN pathology at 14 dpi, indicating that they are less potent than either Hu S87N or Hu TNG PFFs in eliciting a-Syn pathology. The rank-ordered efficiencies with which PFFs induced pathology in vivo are therefore consistent with the seeding efficiency observed in culture.
Examination of PFF-injected brains at 30, 90, and 180 dpi revealed that a-Syn pathology continued to evolve with time in all mice treated with pathogenic PFFs (Figures 4B and 4C) . By 30 dpi, LB-like inclusions were prominent in the amygdala of mice exposed to Hu A53T , Hu S87N , Hu TNG , or Ms WT PFFs. However, only LN-like inclusions could be detected in Hu WT PFF-injected mice, consistent with delayed initiation of seeding in these animals. The appearance of cytoplasmic inclusions occurred at later incubation periods (90 dpi), matching the previously described evolution for seeded a-Syn pathology in vivo (Luk et al., 2012a; Osterberg et al., 2015) . Neuronal inclusions were also labeled with an antibody selective for misfolded a-Syn (Syn506; Waxman et al., 2008) and thioflavin S, confirming pathological a-Syn as a major constituent. However, we failed to observe any pathology in mice injected with Hu TN PFFs through (Luk et al., 2012a; Paumier et al., 2015; Recasens et al., 2014) , we quantified the remaining number of DA neurons in this region at each time point to determine if the rate of inclusion formation correlated with cell loss (Figures 5C and S6) WT PFFs also showed progressive deterioration in rotarod performance that was significant by 180 dpi ( Figure 5D ). Figure S6) . Thus, when differences in PFF internalization and delivery are eliminated, Hu TN PFFs are equally potent to other PFFs in recruiting and converting endogenous a-Syn into pathological aggregates, consistent with observations from our in vitro seeding assays.
Non-pathogenic Chimeric a-Syn PFFs Show Normal Entry into Neurons
Given that Hu TN PFFs are highly efficient in inducing pSyn inclusions when delivered into cells, yet seed poorly when passively administered to neurons or mice, we asked if the internalization of Hu TN PFFs by neurons is compromised. We previously showed that a-Syn PFFs are detectable in >80% of neurons after 6 hr of exposure to Hu WT PFFs (Tran et al., 2014) . Hippocampal neurons derived from Snca À/À mice were used to compare the internalization efficacy of Hu WT , Hu TN , and Ms WT PFFs at 6 and 24 hr post-transduction to eliminate confounds of detecting endogenous a-Syn. All PFF preparations were readily internalized, as indicated by detectable a-Syn positive puncta juxtaposed to markers of early endosomes (EEA-1) and lysosomes (LAMP1) (Figures S6D and S6E ). The proportion of neurons containing internalized a-Syn PFFs was similar across these three constructs, suggesting that the lack of neuronal seeding seen with Hu TN PFFs is not due to an overall reduction in PFF entry into neurons. Similarly, the proportions of neurons containing a-Syn PFF in LAMP1-positive structures were indistinguishable across these fibril types, suggesting that, at least at this early stage, they share a common route of internalization and subcellular processing ( Figures S6F and S6G ). No differences were observed in the proportion of PFF-bearing neurons at 24 hr post-treatment, further indicating that internalization is not responsible for the inability of Hu TN PFFs to induce a-Syn inclusions in neurons (data not shown). , and Hu S87N in Figure 6A ).
Hu
Second, the shift from relatively equivalent amounts of bands (E) DIV10 primary hippocampal neurons were treated for 7 days with 140 nM PFFs and then sequentially extracted with 1% Triton X-100 followed by 2% SDS.
Lysates from Triton and SDS fractions were immunoblotted with Syn9027 (total a-Syn), MJF-R13 (pSyn), and TUJ1 loading control. See also Figure S7 . Figure 7B ). Importantly, none of the bands examined represented truncation events beyond position $32 or $110, terminal areas in which these constructs share identical sequences, thus eliminating the possibility that the substitutions within the Hu TN sequence were responsible for the observed differences. Hu WT had adopted the non-pathogenic state of the Hu TN seeds used to generate this material, demonstrating that both a pathogenic and a non-pathogenic state are transferable between different a-Syn sequences.
DISCUSSION
Recent studies have shown that misfolded a-Syn species template the conversion of native a-Syn into pathological PD-like inclusions, a process that likely underlies the spread of cellular a-Syn pathologies observed in prototypical synucleinopathies such as PD. Although fibril-seeded LN and LB formation has been observed in both neuron cultures and in vivo models, how pathological a-Syn potentiates the conversion of the endogenous normal a-Syn pool is unclear. Our data here show that, similar to other amyloids, PFF-mediated cross-seeding between homologous a-Syn sequences is significantly more efficient than that of Hu and Ms a-Syn. Using a series of Hu-Ms chimeric a-Syn PFFs, we find that at the molecular level, seeding efficiency is determined by sequence homology between the a-Syn PFF seeds and soluble a-Syn monomers.
However, our findings reveal a more complex picture at the cellular level as the in vitro seeding potencies for several PFFs did not directly correlate with their ability to induce pathology. While Hu-Ms cross-seeding is markedly less effective when induced by PFFs in neurons and in vivo, we also identified chimeric a-Syn proteins that give rise to PFFs that either significantly enhanced (Hu S87N and Hu TNG ) or suppressed (Hu  TN ) induction of a-Syn pathologies compared with Ms WT a-Syn PFFs. Among the residues examined, the two residues closest to the core hydrophobic (NAC) domain of a-Syn (53 and 87) show the strongest influence on PFF cross-seeding in vivo, as highlighted by the fact that single substitutions toward resembling either Hu WT or Ms WT immediately restore neuronal seeding activity to Hu TN PFFs, although pathogenicity is also influenced by interactions between these two residues and the C-terminal region (particularly around aa 103-107). Our in vivo data also showed that these altered seeding characteristics apply across multiple brain regions and neuronal subtypes. Most strikingly, Hu TN PFFs have a lower seeding capacity than even Hu WT PFFs in both neuron culture and in vivo despite its greater homology with Ms a-Syn and higher seeding potency in cell-free systems. Thus, in addition to molecular compatibility between seed and substrate, processes operating at the cellular level also determine the efficiency of a-Syn pathology transmission.
When cross-seeded with Hu WT PFFs, Hu TN monomers form pathogenic PFFs. Similarly, Hu WT monomer assembled in the presence of non-pathogenic Hu TN seeds display reduced potency in neurons, making it unlikely that co-purifying contaminants are responsible for the different activities of seeding or non-seeding a-Syn constructs. These data also suggest that pathogenicity can be transferred between these two sequences through in vitro templating, consistent with the notion that a-Syn fibrils can assume multiple conformations (Bousset et al., 2013; Guo et al., 2013) . It is possible that specific fibril conformations have distinct biological activities, although further studies are needed to elucidate the relationship between structure and pathogenicity in neurons. Indeed, our PFF preparations may potentially contain multiple misfolded species with differing pathogenicities, and it is conceivable that alteration of the a-Syn primary sequence could shift this equilibrium.
Our findings present a number of possible, non-exclusive scenarios as to how different a-Syn seeds affect pathological a-Syn propagation. First, PFFs may differ in their ability to enter into neurons. In this regard, we did not detect differences in the internalization or subcellular compartmentalization of Hu TN PFFs versus other pathogenic fibrils, although more sensitive methods are necessary to interrogate specific differences in subcellular localization or if various PFFs differ in their susceptibility to intracellular processing or degradation. Second, neuronal a-Syn is preferentially localized to presynaptic vesicles and is associated with membranes under physiological conditions, where it maintains a different conformation than its unfolded state in cell-free systems (Dettmer et al., 2016) . Therefore, monomeric a-Syn could be highly accessible to pathological a-Syn species of various configurations in solution (hence sequence compatibility governs cell-free seeding rate), whereas membrane-bound a-Syn might interface with only a subset of configurations such as those found within pathogenic PFF preparations (Sidhu et al., 2016) . This remains to be confirmed, although in agreement with this, Hu TN PFFs efficiently induce a-Syn inclusions when transduced into a-Syn overexpressing non-neuronal cells, suggesting a reduced ability to interact with endogenous neuronal a-Syn. Third, pathogenic and non-pathogenic PFFs may differ in their interaction
with as yet unknown co-factors that could facilitate pathological a-Syn seeding in neurons (Supattapone, 2014) .
It is interesting that while the species barrier for the infectious conformer of human prion protein, which in its normal conformation is a surface glycoprotein, is particularly sensitive to changes in the aa sequence, the phenomenon described here for a-Syn, an intracellular protein, shows a dramatic dependence on features beyond primary structure (Cobb and Surewicz, 2009; Collinge and Clarke, 2007) . This suggests that where a seed and the endogenous protein meet is a key consideration for understanding how the various proteins that aggregate in neurodegenerative disease propagate. Further understanding of the fate of internalized seeding-incompetent PFFs composed of Hu TN a-Syn should help elucidate the nature of this initial interaction and thus provide important mechanistic insights into the process of templated a-Syn seeding in neurons.
Finally, our data showing that similar neuroanatomical regions develop a-Syn pathology regardless of the cell-free seeding efficiency of the injected a-Syn PFFs suggest that the sequences described here alter their ability to trigger the initial misfolding of cellular a-Syn and are in line with a model whereby a-Syn pathology is induced through seeding in trans but that subsequent propagation proceeds through cycles of seeding in cis involving primarily endogenous a-Syn. Consistent with this, we observed that DA neuron degeneration was most rapid following injection of Ms WT and chimeric a-Syn PFFs with greater neuronal seeding rates and, consequently, more quickly developing a-Syn pathology. This observation suggests a direct relationship between the onset of a-Syn pathology burden and neuronal toxicity. In summary, our investigation of cross-seeding between Hu and Ms a-Syn has revealed important insights into the pathogenicity of a protein central to neurodegeneration.
EXPERIMENTAL PROCEDURES Animals
Wt (C57BL6/C3H) mice were obtained from the Jackson Laboratories. Primary neuronal cultures were prepared from timed-pregnant (CD-1) mice (Charles River Laboratories) and Snca À/À mice (Abeliovich et al., 2000) that were maintained on a C57BL6 background. All housing, breeding, and procedures were performed according to the National Institutes of Health (NIH) Guide for the Care and Use of Experimental Animals and approved by the University of Pennsylvania Institutional Animal Care and Use Committee.
Recombinant a-Syn Purification and In Vitro Fibrillization
Constructs for chimeric a-Syn proteins were generated through PCR sitedirected mutagenesis with the PRK172/Hu WT a-Syn or PRK172/Ms WT a-Syn plasmid as template. Wt and chimeric a-Syn constructs were expressed in E. coli BL21 (DE3) RIL cells and purified as previously described (Giasson et al., 2001; Luk et al., 2009 Luk et al., , 2012a Volpicelli-Daley et al., 2014) . Fibrillization was conducted by diluting recombinant a-Syn to 360 mM (5 mg/ml) in sterile Dulbecco's PBS (pH 7.0; Mediatech) with constant agitation (1,000 rpm at 37 C) for 7 days in an Eppendorf Thermomixer C with ThermoTop. Successful fibrillization was verified by sedimentation, transmission electron microscopy (TEM) analysis, and ThT binding. Further details are described in Supplemental Experimental Procedures.
Kinetic Analysis of Seeded a-Syn In Vitro Fibrillization
Efficacy of seeding for a particular construct was assayed by adding 1% PFFs (25 mg/ml) into a fibrillization reaction containing 99% freshly thawed and spun Ms WT or Hu WT monomer (2.5 mg/ml in the final reaction). All seeded fibrillization reactions were performed at a final concentration of 2.5 mg/ml (180 mM) and final volume of 750 ml in order to facilitate differentiation of aggregation rates. Sedimentation was performed at the time points indicated. For each a-Syn construct, more than two independently prepared monomer batches were tested for each fibrillization paradigm, and more than two series of seeded fibrillization reactions were run for each monomer batch. Relative quantities of protein in each fraction were assessed by densitometry using a Li-Cor Odyssey scanner at 680 nm. Graphing was performed with GraphPad Prism 4, and the curve-fitting feature of the software was used to generate the elongation rate (Hill slope) and initiation rate (half maximal effective concentration [EC 50 ]) data for Figures 1, S2 , and S3.
Primary Neuron Cultures and Fibril Transduction
Primary neuron cultures were prepared from CD1 or Snca À/À mice on embryonic day 15 to embryonic day 17, as previously described (Volpicelli-Daley et al., 2014) . Dissociated hippocampal neurons were plated onto poly-D-lysine coated coverslips in 24-well plates (100,000 cells/coverslip). Transduction was performed at 10 days in vitro (DIV) using a-Syn PFFs diluted to 2.4 mM in PBS (without Mg 2+ /Ca 2+ ) and sonicated with a Biorupter (Diagenode) at high power for 10 cycles (30 s on, 30 s off at 10 C). At 4 days post-transduction, 30% of the media was gently aspirated from each well and replaced with 200 ml of fresh media. For biochemical studies, PFFs (140 nM) were added to neurons in a 6-well plate containing 1 million cells per well. Transduced neurons were harvested for immunocytochemistry or sequential extraction at 7 days post-transduction (17 DIV).
Proteolytic Digestion of PFFs PK (P-2308), trypsin (T-9201), chymotrypsin (C-4129), and Pronase E (P-5147) were obtained from Sigma and stock solutions prepared in water. Chymotrypsin was dissolved in 1 mM HCl. Ten micrograms of PFFs generated from de novo assembly reactions were digested with the indicated concentrations of protease in Dulbecco's PBS. Digestions were performed in a final volume of 20 ml and incubated at 37 C for either 30 min (PK, trypsin) or 40 min (Pronase E, chymotrypsin). Digestions were stopped with 1 mM PMSF or 100 mM aprotinin. Reaction samples were then boiled with SDS-sample buffer for 5 min and resolved on NuPAGE Novex 12% Bis-Tris gels (Invitrogen) for PK, chymotrypsin, and Pronase E reactions or Novex 16% Tricine gels for trypsin digestions. All experiments were performed three to five times with at least two independently prepared batches of PFFs. Representative images from Coomassie stained gels are shown in Figures 6 and S7.
Stereotaxic Injection of PFFs
Prior to intrastriatal injection, PFFs were first diluted in sterile PBS and sonicated as described above. Mice (2-3 months old) were anesthetized with ketamine hydrochloride (100 mg/kg, intraperitoneal [i.p.]) and xylazine (10 mg/kg, i.p.). A single injection (5 mg PFFs) was stereotaxically injected into the striatum (coordinates: +0.2 mm relative to Bregma, +2.0 mm from midline, +2.6 mm beneath the dura). Injections were made with 10 ml syringes (Hamilton) at a rate of 0.1 ml/min (2.5 ml total) with the needle in place for R5 min at each target. Animals were monitored regularly following recovery from surgery and sacrificed at various pre-determined time points (14, 30, 90 , and 180 dpi) by overdose with ketamine/xylazine. For histological studies the brain and spinal cord were removed after transcardial perfusion with PBS and underwent overnight postfixation in either neutral buffered formalin (Fisher Scientific) or 70% ethanol (in 150 mM NaCl [pH 7.4]), before being processed and embedded in paraffin.
Statistical Analysis
Data from in vitro cross-seeding reactions, neuronal culture experiments, and immunoblot quantification were compared using GraphPad Prism software version 4, using one-way ANOVA. Post hoc testing was performed using the Tukey method. One-way ANOVA was also used to compare in vivo pSyn pathology within select regions of interest at 30 dpi. Comparison of histopathological and behavioral data in the timed-cohort series was performed using Stata software version 11. Means from each group were analyzed using two-way ANOVA with a-Syn PFF treatment and incubation time as factors. Post hoc pairwise comparisons were performed using Tukey's honest significant difference (HSD) method. Results from protease digestion experiments were analyzed by two-way ANOVA (a-Syn PFF and protease concentration as factors). Bonferroni correction was applied to pairwise comparisons. 
SUPPLEMENTAL INFORMATION
